Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

NCT01851954 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped declined enrollment

Conditions

Very Low Birth Weight Infant
Ureaplasma/Mycoplasma Positive

Interventions

DRUG: Clarithromycin

Sponsor

Seoul National University Hospital